Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Receives FDA Emergency Use Authorization for Monkeypox PCR Assay


NEW YORK – Thermo Fisher Scientific said on Wednesday that its monkeypox PCR test has been granted Emergency Use Authorization by the US Food and Drug Administration.

The Applied Biosystems TaqPath Monkeypox/Orthopox Virus DNA Kit is designed to detect DNA from the monkeypox virus and screen for non-variola orthopoxviruses in human lesion swab samples from patients suspected of monkeypox infection, according to Thermo Fisher. While positive test results are indicative of the presence of DNA from the monkeypox virus or other non-variola orthopoxviruses, clinicians must correlate PCR results with patient history and other diagnostic information to determine infection status, the company said.

The FDA has been issuing EUAs for monkeypox tests since September. Before Thermo Fisher, Quest Diagnostics, Roche, and Abbott have obtained EUAs for their monkeypox assays.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.